January Social Media Round-Up—Celebrating 175, Discussing AI, and Attending CES 2024

One month into the new year and Pfizer is already got plenty to show for it.

January’s social media round-up features a dispatch from Las Vegas’s CES conference, our CTO’s insight into artificial intelligence’s impact on cancer, and an impassioned pleas from our CEO.

Catch up below:

CEO Albert Bourla kicks off Pfizer’s 175th anniversary celebration:

https://www.linkedin.com/posts/albert-bourla_2024-marks-a-significant-year-for-pfizer-activity-7150126029393580032-ES_A?utm_source=share&utm_medium=member_desktop

Chief People Experience Office Payal Sahni Becker celebrates Pfizer’s inclusion on Fortune’s Most Admired Companies list:

https://www.linkedin.com/feed/update/urn:li:activity:7159211335610699776/

CEO Albert Bourla TIME Op-Ed urging action for Israeli hostages in Gaza:

https://www.linkedin.com/posts/albert-bourla_column-my-call-to-action-for-the-israeli-activity-7155195894412230656-x3i4?utm_source=share&utm_medium=member_desktop

Chief Marketing Officer Drew Panayiotou reports back on his experience at CES 2024:

https://www.linkedin.com/posts/drewpanayiotou_ces2024-ai-activity-7151732623998930944-45mi

CEO Albert Bourla lists some of the company’s 2023 highlights:

https://www.linkedin.com/posts/albert-bourla_pfizerproud-activity-7158185661068427266-WWcI

Chief Digital and Technology Officer Lidia Fonseca shares her discussion with Forbes about AI’s impact on healthcare and the future of cancer treatment:

https://www.linkedin.com/feed/update/urn:li:activity:7159219986593386496